Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study

Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study / Birolo, C; Zannin, Me; Arsenyeva, S; Cimaz, R; Miserocchi, E; Dubko, M; Deslandre, C; Falcini, F; Alessio, M; La Torre, F; Denisova, E; Nikishina, I; Zulian, F. - STAMPA. - (2012), pp. 716-716. (Intervento presentato al convegno Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)).

Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study

CIMAZ, ROLANDO;FALCINI, FERNANDA;
2012

Abstract

Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study
2012
Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)
Birolo, C; Zannin, Me; Arsenyeva, S; Cimaz, R; Miserocchi, E; Dubko, M; Deslandre, C; Falcini, F; Alessio, M; La Torre, F; Denisova, E; Nikishina, I; ...espandi
4b - Riassunto in atti di congresso
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1059568
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact